Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | FABP1 | P07148 | 1/20 | 0.56 |
| ▸ | FABP6 | P51161 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 5/20 | 0.55 |
| ▸ | RAB9A | P51151 | 5/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | PIM1 | P11309 | 1/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | FLT3 | P36888 | 1/20 | 0.51 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.51 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.51 |
| ▸ | FDPS | P14324 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL360682 | 1.00 | GAA (0.56) | GAAFABP1FABP6NPC1RAB9A | |
| SCHEMBL9722609 | 0.86 | GAA (0.58) | GAAFABP1FABP6NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL14914649 | 0.84 | ITGB3 (0.61) | GAAFABP1FABP6NPC1RAB9A | |
| SCHEMBL13589538 | 0.83 | GAA (0.55) | GAAFABP1FABP6NPC1RAB9A | |
| SCHEMBL2857962 | 0.83 | GAA (0.55) | GAAFABP1FABP6NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL7494264 | 0.82 | GAA (0.50) | GAAFABP1FABP6NPC1RAB9A | |
| SCHEMBL3615506 | 0.81 | GAA (0.53) | GAANPC1RAB9APKMSMN1; SMN2 | |
| SCHEMBL243759 | 0.81 | ITGB3 (0.63) | GAAFABP1FABP6NPC1RAB9A | |
| SCHEMBL28664986 | 0.81 | GAA (0.53) | GAAFABP1FABP6NPC1RAB9A | |
| SCHEMBL5845136 | 0.81 | ITGB3 (0.55) | GAAFABP1FABP6NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114324663-B | Method for detecting lornoxicam-related substances | 北京金城泰尔制药有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-114324663-A | Method for detecting lornoxicam related substances | 北京金城泰尔制药有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-2415763-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | UBE INDUSTRIES (JP) | 2016-01-27 | — | — | EP | claimed |
| CN-102448940-B | For the medical composition of glaucomatous treatment or prevention | UBE INDUSTRIES, LTD. (JP) | 2015-10-21 | — | — | CN | claimed |
| CN-103965099-A | Pyridylaminoacetic Acid Compound | UBE INDUSTRIES | 2014-08-06 | — | — | CN | claimed |
| CN-101970410-B | Pyridylaminoacetic acid compounds | UBE INDUSTRIES | 2014-06-25 | — | — | CN | claimed |
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2014-04-24 | — | — | US | claimed |
| US-8648097-B2 | Pyridylaminoacetic acid compound | UBE INDUSTRIES, LTD. (JP) | 2014-02-11 | — | — | US | claimed |
| US-20120190852-A1 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF GLAUCOMA | UBE INDUSTRIES, LTD. (JP) | 2012-07-26 | — | — | US | claimed |
| CN-102448940-A | Pharmaceutical composition for treating or preventing glaucoma | UBE INDUSTRIES | 2012-05-09 | — | — | CN | claimed |
| EP-2415763-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | Ube Industries, Ltd. (JP) | 2012-02-08 | — | — | EP | claimed |
| US-20110054172-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE CORPORATION (JP) | 2011-03-03 | — | — | US | claimed |
| CN-101970410-A | Pyridylaminoacetic acid compounds | UBE INDUSTRIES | 2011-02-09 | — | — | CN | claimed |
| EP-2264009-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | Ube Industries, Ltd. (JP) | 2010-12-22 | — | — | EP | claimed |
| EP-0966454-B1 | DISUBSTITUTED BICYCLIC HETEROCYCLES, THEIR PRODUCTION AND USE AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-05-07 | — | — | EP | claimed |
| US-12636367-B2 | Pharmaceutical composition containing pyridylaminoacetic acid compound | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12636367-B2 | Pharmaceutical composition containing pyridylaminoacetic acid compound | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-0017009-B1 | DYES AND TINTS BASED ON OPTIONALLY SUBSTITUTED 2-AMINO-5-IMINOPYRROLENINES | BAYER AG (DE) | 1983-12-28 | — | — | EP | disclosed |
| EP-0017009-A2 | Dyes and tints based on optionally substituted 2-amino-5-iminopyrrolenines | BAYER AG (DE) | 1980-10-15 | — | — | EP | disclosed |
| US-4088816-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | PTGER2, PTGER1, PTGDR2 | GAA 2639/4885FABP1 2742/4885FABP6 1686/4885 |
| US-20110054172-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | PTGER2, PTGER1, PTGDR2 | GAA 2602/4885FABP1 2819/4885FABP6 1687/4885 |
| US-20120190852-A1 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF GLAUCOMA | F12, C1S, AKR1C3 | GAA 1887/4885FABP1 1192/4885FABP6 850/4885 |
| US-12636367-B2 | Pharmaceutical composition containing pyridylaminoacetic acid compound | PHOSPHO1, PCCA, PGAM1 | GAA 541/4885FABP1 2434/4885FABP6 2237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.